Novo Nordisk invests $4.1B to expand Ozempic production in Clayton, NC

Novo Nordisk announced plans to invest about $4.1 billion to expand production capability for its GLP-1 drug Ozempic at its Clayton, North Carolina facility. Construction is already underway on the 56-acre site, with about 2,000 external contractors expected at peak.

“Novo Nordisk announced plans to invest about $4.1 billion to expand their production capability to manufacture more of their GLP-1 drug 'Ozempic' at their Clayton North Carolina facility.”uspublicworks.com

• 1 source
• uspublicworks.comBillion Dollar Projects - Welcome to US Public Works -Jul 17, 2022

Summarized from public sources; check the original articles before acting on it.